KONINKLIJKE PHILIPS NV (PHIA.AS) Fundamental Analysis & Valuation
AMS:PHIA • NL0000009538
Current stock price
25.35 EUR
+0.67 (+2.71%)
Last:
This PHIA.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. PHIA.AS Profitability Analysis
1.1 Basic Checks
- PHIA had positive earnings in the past year.
- In the past year PHIA had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
- PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- PHIA has a Return On Assets (3.32%) which is in line with its industry peers.
- PHIA has a Return On Equity (8.17%) which is comparable to the rest of the industry.
- PHIA has a Return On Invested Capital (5.50%) which is in line with its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for PHIA is significantly below the industry average of 10.15%.
- The last Return On Invested Capital (5.50%) for PHIA is above the 3 year average (3.48%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.32% | ||
| ROE | 8.17% | ||
| ROIC | 5.5% |
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
1.3 Margins
- PHIA's Profit Margin of 5.02% is in line compared to the rest of the industry. PHIA outperforms 44.44% of its industry peers.
- PHIA's Profit Margin has declined in the last couple of years.
- The Operating Margin of PHIA (7.98%) is comparable to the rest of the industry.
- In the last couple of years the Operating Margin of PHIA has declined.
- The Gross Margin of PHIA (45.18%) is worse than 77.78% of its industry peers.
- PHIA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.98% | ||
| PM (TTM) | 5.02% | ||
| GM | 45.18% |
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
2. PHIA.AS Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHIA is destroying value.
- PHIA has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, PHIA has more shares outstanding
- The debt/assets ratio for PHIA is higher compared to a year ago.
2.2 Solvency
- PHIA has an Altman-Z score of 2.02. This is not the best score and indicates that PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.02, PHIA is in line with its industry, outperforming 44.44% of the companies in the same industry.
- PHIA has a debt to FCF ratio of 16.37. This is a negative value and a sign of low solvency as PHIA would need 16.37 years to pay back of all of its debts.
- PHIA has a Debt to FCF ratio (16.37) which is comparable to the rest of the industry.
- A Debt/Equity ratio of 0.63 indicates that PHIA is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.63, PHIA is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 16.37 | ||
| Altman-Z | 2.02 |
ROIC/WACC0.87
WACC6.34%
2.3 Liquidity
- A Current Ratio of 1.32 indicates that PHIA should not have too much problems paying its short term obligations.
- PHIA has a Current ratio (1.32) which is in line with its industry peers.
- PHIA has a Quick Ratio of 1.32. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of PHIA (0.94) is worse than 60.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.94 |
3. PHIA.AS Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 6.11% over the past year.
- The Earnings Per Share has been decreasing by -6.62% on average over the past years.
- PHIA shows a decrease in Revenue. In the last year, the revenue decreased by -1.03%.
- Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 0.59% on average per year.
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
3.2 Future
- Based on estimates for the next years, PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.24% on average per year.
- The Revenue is expected to grow by 3.78% on average over the next years.
EPS Next Y3.11%
EPS Next 2Y8.19%
EPS Next 3Y10.16%
EPS Next 5Y10.24%
Revenue Next Year1.3%
Revenue Next 2Y2.87%
Revenue Next 3Y3.49%
Revenue Next 5Y3.78%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. PHIA.AS Valuation Analysis
4.1 Price/Earnings Ratio
- PHIA is valuated rather expensively with a Price/Earnings ratio of 17.24.
- 85.71% of the companies in the same industry are more expensive than PHIA, based on the Price/Earnings ratio.
- PHIA is valuated rather cheaply when we compare the Price/Earnings ratio to 27.87, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 16.72, which indicates a correct valuation of PHIA.
- Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than the industry average as 63.49% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 38.51, PHIA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.24 | ||
| Fwd PE | 16.72 |
4.2 Price Multiples
- 71.43% of the companies in the same industry are more expensive than PHIA, based on the Enterprise Value to EBITDA ratio.
- The rest of the industry has a similar Price/Free Cash Flow ratio as PHIA.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 49.41 | ||
| EV/EBITDA | 11.4 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHIA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.54
PEG (5Y)N/A
EPS Next 2Y8.19%
EPS Next 3Y10.16%
5. PHIA.AS Dividend Analysis
5.1 Amount
- No dividends for PHIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PHIA.AS Fundamentals: All Metrics, Ratios and Statistics
AMS:PHIA (4/17/2026, 7:00:00 PM)
25.35
+0.67 (+2.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10 2026-02-10/bmo
Earnings (Next)05-06 2026-05-06
Inst Owners48.33%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap24.41B
Revenue(TTM)17.84B
Net Income(TTM)895.00M
Analysts74.67
Price Target29.14 (14.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.35
Dividend Growth(5Y)216.55%
DP36.65%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.02%
Min EPS beat(2)3.95%
Max EPS beat(2)14.1%
EPS beat(4)4
Avg EPS beat(4)17.83%
Min EPS beat(4)3.95%
Max EPS beat(4)31.04%
EPS beat(8)4
Avg EPS beat(8)2.84%
EPS beat(12)6
Avg EPS beat(12)6.47%
EPS beat(16)7
Avg EPS beat(16)6.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.36%
Revenue beat(16)2
Avg Revenue beat(16)-1.72%
PT rev (1m)-0.61%
PT rev (3m)5.64%
EPS NQ rev (1m)-0.95%
EPS NQ rev (3m)-33.29%
EPS NY rev (1m)-0.89%
EPS NY rev (3m)-0.71%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)5.94%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-1.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.24 | ||
| Fwd PE | 16.72 | ||
| P/S | 1.37 | ||
| P/FCF | 49.41 | ||
| P/OCF | 21.01 | ||
| P/B | 2.23 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.4 |
EPS(TTM)1.47
EY5.8%
EPS(NY)1.52
Fwd EY5.98%
FCF(TTM)0.51
FCFY2.02%
OCF(TTM)1.21
OCFY4.76%
SpS18.52
BVpS11.38
TBVpS-0.92
PEG (NY)5.54
PEG (5Y)N/A
Graham Number19.4007 (-23.47%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.32% | ||
| ROE | 8.17% | ||
| ROCE | 7.33% | ||
| ROIC | 5.5% | ||
| ROICexc | 6.42% | ||
| ROICexgc | 22.25% | ||
| OM | 7.98% | ||
| PM (TTM) | 5.02% | ||
| GM | 45.18% | ||
| FCFM | 2.77% |
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
ROICexc(3y)3.99%
ROICexc(5y)N/A
ROICexgc(3y)13.73%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.19%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.56%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 16.37 | ||
| Debt/EBITDA | 2.72 | ||
| Cap/Depr | 59.38% | ||
| Cap/Sales | 3.75% | ||
| Interest Coverage | 5.63 | ||
| Cash Conversion | 45.59% | ||
| Profit Quality | 55.2% | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | 2.02 |
F-Score7
WACC6.34%
ROIC/WACC0.87
Cap/Depr(3y)53.03%
Cap/Depr(5y)53.41%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
EPS Next Y3.11%
EPS Next 2Y8.19%
EPS Next 3Y10.16%
EPS Next 5Y10.24%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
Revenue Next Year1.3%
Revenue Next 2Y2.87%
Revenue Next 3Y3.49%
Revenue Next 5Y3.78%
EBIT growth 1Y15922.2%
EBIT growth 3YN/A
EBIT growth 5Y-4.71%
EBIT Next Year68.02%
EBIT Next 3Y26.32%
EBIT Next 5Y17.86%
FCF growth 1Y-43.86%
FCF growth 3YN/A
FCF growth 5Y-22.31%
OCF growth 1Y-25.32%
OCF growth 3YN/A
OCF growth 5Y-15.14%
KONINKLIJKE PHILIPS NV / PHIA.AS Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?
ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.
What is the valuation status for PHIA stock?
ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.
What is the profitability of PHIA stock?
KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 3 / 10.
What is the financial health of KONINKLIJKE PHILIPS NV (PHIA.AS) stock?
The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 2 / 10.
Can you provide the expected EPS growth for PHIA stock?
The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NV (PHIA.AS) is expected to grow by 3.11% in the next year.